Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Aminoxyrone
ID: ALA5281169
Max Phase: Preclinical
Molecular Formula: C50H71N7O14
Molecular Weight: 994.15
Associated Items:
ID: ALA5281169
Max Phase: Preclinical
Molecular Formula: C50H71N7O14
Molecular Weight: 994.15
Associated Items:
Canonical SMILES: CC[C@@H](C)[C@@H](ONC(=O)[C@H](ONC(=O)[C@@H](Cc1ccccc1)ONC(=O)[C@@H](Cc1ccccc1)ONC(=O)OCc1ccccc1)[C@H](C)CC)C(=O)NO[C@H](CC(C)C)C(=O)NO[C@H](CC(C)C)C(N)=O
Standard InChI: InChI=1S/C50H71N7O14/c1-9-33(7)42(48(62)55-67-39(27-32(5)6)45(59)52-66-38(44(51)58)26-31(3)4)71-56-49(63)43(34(8)10-2)70-54-47(61)40(28-35-20-14-11-15-21-35)68-53-46(60)41(29-36-22-16-12-17-23-36)69-57-50(64)65-30-37-24-18-13-19-25-37/h11-25,31-34,38-43H,9-10,26-30H2,1-8H3,(H2,51,58)(H,52,59)(H,53,60)(H,54,61)(H,55,62)(H,56,63)(H,57,64)/t33-,34-,38-,39-,40-,41-,42-,43-/m1/s1
Standard InChI Key: AGECUNGTQVMLRM-MBRFLKKPSA-N
Molfile:
RDKit 2D 71 73 0 0 0 0 0 0 0 0999 V2000 -5.7186 -1.0310 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.0042 -0.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0042 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2894 -1.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7189 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4338 0.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.1459 0.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.1459 1.4444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4355 1.8564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7189 1.4481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5747 -0.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.2894 -1.8564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.8601 -1.0311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.1453 -0.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4306 -1.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1453 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8601 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7160 -0.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.4306 -1.8564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.0012 -1.0311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7134 -0.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4280 -1.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7134 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0012 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4280 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4280 1.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5749 0.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2871 0.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2871 1.4444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5767 1.8564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8601 1.4481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1428 -0.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4280 -1.8564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8575 -1.0311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5721 -0.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2869 -1.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5721 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8575 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2869 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2869 1.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0016 -0.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.2869 -1.8564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.7163 -1.0311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.4310 -0.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1457 -1.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.4310 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1457 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1457 1.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.8604 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.8604 -0.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 7.1457 -1.8564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.5751 -1.0311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.2898 -0.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.0045 -1.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.2898 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.0045 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.0045 1.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.7192 0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.7192 -0.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10.0045 -1.8564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.4333 -0.6183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -7.1481 -1.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.8628 -0.6183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -7.1481 -1.8563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -8.5774 -1.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -9.2922 -0.6183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.0070 -1.0308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.7192 -0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.7192 0.2066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.0088 0.6186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -9.2922 0.2103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 6 2 4 1 0 3 5 1 0 6 5 2 0 7 6 1 0 8 7 2 0 9 8 1 0 10 9 2 0 5 10 1 0 4 11 1 0 4 12 2 0 11 13 1 0 13 14 1 0 14 15 1 0 14 16 1 6 16 17 1 0 15 18 1 0 15 19 2 0 18 20 1 0 20 21 1 0 21 22 1 6 21 23 1 0 23 24 1 6 23 25 1 0 25 26 1 0 27 17 2 0 28 27 1 0 29 28 2 0 30 29 1 0 31 30 2 0 17 31 1 0 22 32 1 0 22 33 2 0 32 34 1 0 34 35 1 0 35 36 1 6 35 37 1 0 37 38 1 6 37 39 1 0 39 40 1 0 36 41 1 0 36 42 2 0 41 43 1 0 43 44 1 0 44 45 1 0 44 46 1 6 46 47 1 0 47 48 1 0 47 49 1 0 45 50 1 0 45 51 2 0 50 52 1 0 52 53 1 0 53 54 1 0 53 55 1 6 55 56 1 0 56 57 1 0 56 58 1 0 54 59 1 0 54 60 2 0 1 61 1 0 61 62 1 0 62 63 1 0 62 64 2 0 63 65 1 0 65 66 1 0 67 66 2 0 68 67 1 0 69 68 2 0 70 69 1 0 71 70 2 0 66 71 1 0 M END
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 994.15 | Molecular Weight (Monoisotopic): 993.5059 | AlogP: 4.45 | #Rotatable Bonds: 32 |
Polar Surface Area: 282.30 | Molecular Species: ACID | HBA: 14 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.80 | CX Basic pKa: ┄ | CX LogP: 7.49 | CX LogD: 2.77 |
Aromatic Rings: 3 | Heavy Atoms: 71 | QED Weighted: 0.04 | Np Likeness Score: 0.05 |
1. Amatya E, Blagg BSJ.. (2023) Recent advances toward the development of Hsp90 C-terminal inhibitors., 80 [PMID:36549397] [10.1016/j.bmcl.2022.129111] |
Source(1):